SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0    0 We conducted a randomized , controlled , double-blind , prospective study to evaluate the effect of intraoperative bupivacaine injection on postoperative pain control following Bovie cautery-assisted tonsillectomy in 26 adults .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0    0 We_PPIS2 conducted_VVD a_AT1 randomized_JJ@ ,_Y controlled_VVD_VVN ,_Y double-blind_JJ_NN1@ ,_Y prospective_JJ study_NN1 to_TO evaluate_VVI the_AT effect_NN1 of_IO intraoperative_JJ bupivacaine_NN1 injection_NN1 on_II postoperative_JJ pain_NN1 control_NN1_VV0 following_II@_VVG Bovie_NP1 cautery-assisted_JJ_NN1 tonsillectomy_NN1 in_II 26_MC adults_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0    1 Sixteen patients were injected with 10 ml of 0.5% bupivacaine with 1:200,000 epinephrine , and 10 were injected with 10 ml of normal saline solution .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0    1 Sixteen_MC patients_NN2 were_VBDR injected_VVN with_IW 10_MC ml_NNU of_IO 0.5%_FO bupivacaine_VV0_NN1 with_IW 1:200,000_MC epinephrine_JJ_NN1 ,_Y and_CC 10_MC were_VBDR injected_VVN with_IW 10_MC ml_NNU of_IO normal_JJ saline_JJ solution_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0    2 For 10 days after surgery , patients completed a questionnaire to rate their overall pain and to record their narcotic consumption and oral intake .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0    2 For_IF 10_MC days_NNT2 after_II_CS surgery_NN1 ,_Y patients_NN2 completed_VVD_VVN a_AT1 questionnaire_NN1 to_II rate_NN1 their_APPGE overall_JJ_NN1 pain_NN1 and_CC to_TO record_VVI their_APPGE narcotic_NN1 consumption_NN1 and_CC oral_JJ_NN1 intake_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0    3 At study 's end , there was no statistically significant difference in pain scores , narcotic use , and oral intake between the bupivacaine group and the controls ( p = 0.13 , 0.37 , and 0.35 , respectively ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0    3 At_II study_NN1 's_GE end_NN1 ,_Y there_EX was_VBDZ no_AT_RR%_UH statistically_RR significant_JJ difference_NN1 in_II pain_NN1 scores_NN2 ,_Y narcotic_NN1 use_NN1_VV0 ,_Y and_CC oral_JJ_NN1 intake_NN1 between_II the_AT bupivacaine_NN1 group_NN1 and_CC the_AT controls_NN2 (_Y p_ZZ1 =_FO 0.13_MC ,_Y 0.37_MC ,_Y and_CC 0.35_MC ,_Y respectively_RR )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0    4 We conclude that the effects of perioperative bupivacaine on postoperative pain control in tonsillectomy patients are similar to those of placebo .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0    4 We_PPIS2 conclude_VV0 that_CST the_AT effects_NN2 of_IO perioperative_JJ bupivacaine_NN1 on_II postoperative_JJ pain_NN1 control_NN1_VV0 in_II tonsillectomy_NN1 patients_NN2 are_VBR similar_JJ to_II those_DD2 of_IO placebo_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0    5 Postoperative pain is the primary morbidity associated with tonsillectomy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0    5 Postoperative_JJ pain_NN1 is_VBZ the_AT primary_JJ_NN1 morbidity_NN1 associated_VVN with_IW tonsillectomy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0    6 Various surgical and pharmacologic strategies have been undertaken in an effort to reduce post-tonsillectomy pain .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0    6 Various_JJ surgical_JJ and_CC pharmacologic_JJ strategies_NN2 have_VH0 been_VBN undertaken_VVN in_II an_AT1 effort_NN1 to_TO reduce_VVI post-tonsillectomy_JJ_NN1 pain_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0    7 Surgical advancements have included the introduction of harmonic scalpel tonsillectomy , **27;18489;TOOLONG ( KTP ) laser ablation have included the perioperative administration of steroids , antibiotics , and anesthetics .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0    7 Surgical_JJ advancements_NN2 have_VH0 included_VVN the_AT introduction_NN1 of_IO harmonic_JJ scalpel_NN1 tonsillectomy_NN1 ,_Y **27;18489;TOOLONG_NN1_JJ (_Y KTP_NP1 )_Y laser_NN1 ablation_NN1 have_VH0 included_VVN the_AT perioperative_JJ administration_NN1 of_IO steroids_NN2 ,_Y antibiotics_NN2 ,_Y and_CC anesthetics_NN2_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0    8 The influence of local anesthesia on the course of post-tonsillectomy pain is ambiguous .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0    8 The_AT influence_NN1 of_IO local_JJ anesthesia_NN1 on_II the_AT course_NN1 of_IO post-tonsillectomy_JJ_NN1 pain_NN1 is_VBZ ambiguous_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0    9 Ginstrm et al reported that while intraoperative infiltration of bupivacaine/epinephrine resulted in a significant decrease in intraoperative blood loss , it had only a marginal effect on pain ; what effect it did have was principally seen in the postoperative anesthesia care unit. n1 In a pediatric population , Naja et al found that a preincision injection of local anesthesia resulted in significantly less postoperative pain at rest , on jaw opening , and during intake of a soft diet compared with findings in a placebo group and a general anesthesia group. n2 Previously published data by our group indicated that patients who underwent local infiltration of bupivacaine into the tonsillar fossa immediately following tonsillectomy did not have less pain than did placebo controls. n3 We conducted the present randomized , controlled , double-blind , prospective study to test our earlier findings and to perhaps determine if there is a role for local anesthesia in reducing post-tonsillectomy pain .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0    9 Ginstrm_VV0_NP1@ et_RA21 al_RA22 reported_VVD that_CST while_CS intraoperative_JJ infiltration_NN1 of_IO bupivacaine/epinephrine_NN1 resulted_VVN_VVD in_II a_AT1 significant_JJ decrease_NN1 in_II intraoperative_JJ blood_NN1 loss_NN1 ,_Y it_PPH1 had_VHD only_RR a_AT1 marginal_JJ effect_NN1 on_II pain_NN1 ;_Y what_DDQ effect_VV0@ it_PPH1 did_VDD have_VHI was_VBDZ principally_RR seen_VVN in_II the_AT postoperative_JJ anesthesia_NN1 care_NN1_VV0 unit._NNU n1_FO In_II a_AT1 pediatric_JJ population_NN1 ,_Y Naja_NP1 et_RA21 al_RA22 found_VVD that_CST a_AT1 preincision_NN1 injection_NN1 of_IO local_JJ anesthesia_NN1 resulted_VVN_VVD in_II significantly_RR less_RGR postoperative_JJ pain_NN1 at_II rest_NN1 ,_Y on_II jaw_NN1 opening_NN1_VVG ,_Y and_CC during_II intake_NN1 of_IO a_AT1 soft_JJ diet_NN1 compared_VVN with_IW findings_NN2 in_II a_AT1 placebo_NN1 group_NN1 and_CC a_AT1 general_JJ_NN1 anesthesia_NN1 group._NNU n2_FO Previously_RR published_VVN_VVD_JJ@ data_NN by_II our_APPGE group_NN1 indicated_VVD_VVN that_CST patients_NN2 who_PNQS underwent_VVD local_JJ infiltration_NN1 of_IO bupivacaine_NN1 into_II the_AT tonsillar_JJ fossa_NN1 immediately_RR_CS@ following_VVG_JJ@ tonsillectomy_NN1 did_VDD not_XX have_VHI less_DAR pain_NN1 than_CSN did_VDD placebo_NN1 controls._NNU n3_FO We_PPIS2 conducted_VVD the_AT present_NN1 randomized_VVD ,_Y controlled_VVD_VVN ,_Y double-blind_JJ_NN1@ ,_Y prospective_JJ study_NN1 to_TO test_VVI our_APPGE earlier_JJR findings_NN2 and_CC to_TO perhaps_RR determine_VVI if_CSW@_CS there_EX is_VBZ a_AT1 role_NN1 for_IF local_JJ anesthesia_NN1 in_II reducing_VVG post-tonsillectomy_JJ_NN1 pain_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   10 Patients and methods Study population men and 20 women ( mean age : 24.5 5.8 yr ) -- who had undergone tonsillectomy for either chronic tonsillitis or tonsillar hypertrophy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   10 Patients_NN2 and_CC methods_NN2 Study_VV0@_NN1 population_NN1 men_NN2 and_CC 20_MC women_NN2 (_Y mean_JJ_VV0 age_NN1 :_Y 24.5_MC 5.8_MC yr_NNU )_Y --_NN1 who_PNQS had_VHD undergone_VVN tonsillectomy_NN1 for_IF either_RR chronic_JJ tonsillitis_NN1 or_CC tonsillar_JJ hypertrophy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   11 The number of infections per year ranged from 3 to 7 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   11 The_AT number_NN1 of_IO infections_NN2 per_II year_NNT1 ranged_VVN_VVD from_II 3_MC to_II 7_MC ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   12 Surgical technique .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   12 Surgical_JJ technique_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   13 All patients underwent Bovie cautery-assisted tonsillectomy after induction of general anesthesia .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   13 All_DB patients_NN2 underwent_VVD Bovie_NP1 cautery-assisted_JJ_NN1 tonsillectomy_NN1 after_II_CS induction_NN1 of_IO general_JJ_NN1 anesthesia_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   14 Anesthesia was standardized for all patients ; induction of propofol was followed by nitrous oxide and isoflurane for maintenance .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   14 Anesthesia_NN1_NP1@ was_VBDZ standardized_VVN for_IF all_DB patients_NN2 ;_Y induction_NN1 of_IO propofol_NN1 was_VBDZ followed_VVN by_II nitrous_JJ oxide_NN1 and_CC isoflurane_NN1 for_IF maintenance_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   15 Intraoperative pain management consisted of intravenous fentanyl 2 g/kg , and paralysis was managed with intravenous mivacurium 0.1 mg/kg .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   15 Intraoperative_JJ pain_NN1 management_NN1 consisted_VVN_VVD of_IO intravenous_JJ fentanyl_NN1 2_MC g/kg_NNU ,_Y and_CC paralysis_NN1 was_VBDZ managed_VVN with_IW intravenous_JJ mivacurium_NN1 0.1_MC mg/kg_NNU ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   16 No agents to reverse neuromuscular blockade were used .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   16 No_AT agents_NN2 to_TO reverse_VVI neuromuscular_JJ blockade_NN1 were_VBDR used_VVN ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   17 Patients did not receive perioperative morphine , antiemetics , or steroids .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   17 Patients_NN2 did_VDD not_XX receive_VVI perioperative_JJ morphine_NN1 ,_Y antiemetics_NN2_NN1 ,_Y or_CC steroids_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   18 Following completion of the actual tonsillectomy portion of the operation , patients received a 10-ml injection of either 0.5% bupivacaine with 1:200,000 epinephrine ( n = 16 ) or normal saline solution ( n = 10 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   18 Following_VVG_JJ@_II@ completion_NN1 of_IO the_AT actual_JJ tonsillectomy_NN1 portion_NN1 of_IO the_AT operation_NN1 ,_Y patients_NN2 received_VVD_VVN a_AT1 10-ml_JJ injection_NN1 of_IO either_DD1_RR 0.5%_FO bupivacaine_VV0_NN1 with_IW 1:200,000_MC epinephrine_NN1_JJ (_Y n_ZZ1 =_FO 16_MC )_Y or_CC normal_JJ saline_JJ solution_NN1 (_Y n_ZZ1 =_FO 10_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   19 Patients had been randomized prior to surgery , and the surgeon was blinded to the type of injection .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   19 Patients_NN2 had_VHD been_VBN randomized_VVN@ prior_II21 to_II22 surgery_NN1 ,_Y and_CC the_AT surgeon_NN1 was_VBDZ blinded_VVN to_II the_AT type_NN1 of_IO injection_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   20 Injections were made in a serial fashion to include the base of the uvula and the anterior and posterior tonsillar fossae Then the stomach contents were aspirated , and patients were awakened from anesthesia and extubated .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   20 Injections_NN2 were_VBDR made_VVN in_II a_AT1 serial_JJ_NN1 fashion_NN1 to_TO include_VVI the_AT base_NN1 of_IO the_AT uvula_NN1_JJ and_CC the_AT anterior_JJ and_CC posterior_JJ tonsillar_JJ fossae_NN2 Then_RT the_AT stomach_NN1 contents_NN2 were_VBDR aspirated_VVN@_JJ@ ,_Y and_CC patients_NN2 were_VBDR awakened_VVN from_II anesthesia_NN1 and_CC extubated_VVN ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   21 Postoperative care .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   21 Postoperative_JJ care_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   22 In the postanesthesia care unit , patients were given morphine as needed for pain and ondansetron as needed for nausea and vomiting .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   22 In_II the_AT postanesthesia_NN1 care_NN1 unit_NN1 ,_Y patients_NN2 were_VBDR given_VVN_JJ@ morphine_NN1 as_CSA needed_VVN for_IF pain_NN1 and_CC ondansetron_NN1 as_CSA needed_VVN for_IF nausea_NN1 and_CC vomiting_VVG_NN1@ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   23 Discharge medications included amoxicillin or a first-generation cephalosporin for 10 days and either acetaminophen/codeine 120/12 mg per 5 ml for pain or another narcotic preparation if acetaminophen/codeine was not tolerated .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   23 Discharge_VV0_NN1 medications_NN2 included_VVD_VVN amoxicillin_NN1 or_CC a_AT1 first-generation_JJ cephalosporin_NN1 for_IF 10_MC days_NNT2 and_CC either_DD1 acetaminophen/codeine_NN1 120/12_MF mg_NNU per_II 5_MC ml_NNU for_IF pain_NN1 or_CC another_DD1 narcotic_NN1 preparation_NN1 if_CS acetaminophen/codeine_NN1 was_VBDZ not_XX tolerated_VVN ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   24 Self-assessments .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   24 Self-assessments_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   25 For 10 days postoperatively , patients were asked to rate their pain on a scale of 0 ( none ) to 10 ( severe ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   25 For_IF 10_MC days_NNT2 postoperatively_RR ,_Y patients_NN2 were_VBDR asked_VVN@ to_II rate_NN1 their_APPGE pain_NN1 on_II a_AT1 scale_NN1 of_IO 0_MC (_Y none_PN )_Y to_II 10_MC (_Y severe_JJ )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   26 They were also asked to record the amount of narcotic pain medication they required and the amount of oral intake they were able to achieve .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   26 They_PPHS2 were_VBDR also_RR asked_VVN to_TO record_VVI the_AT amount_NN1 of_IO narcotic_NN1 pain_NN1 medication_NN1 they_PPHS2 required_VVD@_VVN and_CC the_AT amount_NN1 of_IO oral_JJ_NN1 intake_NN1 they_PPHS2 were_VBDR able_JK to_TO achieve_VVI ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   27 Statistical analysis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   27 Statistical_JJ analysis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   28 The data were analyzed according to the Student t test , and a p value of &lt;0.05 was considered to be statistically significant .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   28 The_AT data_NN were_VBDR analyzed_VVN@ according_II21 to_II22 the_AT Student_NN1 t_ZZ1 test_VV0_NN1 ,_Y and_CC a_AT1 p_NN1@_ZZ1_NNU@ value_NN1 of_IO &lt;0.05_FO was_VBDZ considered_VVN to_TO be_VBI statistically_RR significant_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   29 Approval .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   29 Approval_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   30 This study was approved by the UVA Institutional Review Board .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   30 This_DD1 study_NN1 was_VBDZ approved_VVN by_II the_AT UVA_NN1_NP1 Institutional_JJ Review_NN1 Board_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   31 Results Pain .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   31 Results_NN2 Pain_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   32 The mean pain scores in the treatment group and the control group were plotted over time ( figure 1 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   32 The_AT mean_JJ pain_NN1 scores_NN2_VVZ@ in_II the_AT treatment_NN1 group_NN1 and_CC the_AT control_NN1 group_NN1 were_VBDR plotted_VVN over_II time_NNT1 (_Y figure_NN1_VV0@ 1_MC1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   33 groups ( p = 0.13 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   33 groups_NN2 (_Y p_ZZ1 =_FO 0.13_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   34 The pain in the bupivacaine group did not begin to subside until postoperative day 5 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   34 The_AT pain_NN1 in_II the_AT bupivacaine_NN1 group_NN1 did_VDD not_XX begin_VVI to_TO subside_VVI until_CS_II@ postoperative_JJ day_NNT1 5_MC ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   35 Figure 1 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   35 Figure_VV0@_NN1 1_MC1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   36 Mean pain scores in the 2 groups were not significantly different over time ( p = 0.13 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   36 Mean_JJ_VV0 pain_NN1 scores_NN2_VVZ@ in_II the_AT 2_MC groups_NN2 were_VBDR not_XX significantly_RR different_JJ over_II time_NNT1 (_Y p_ZZ1 =_FO 0.13_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   37 Narcotic use .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   37 Narcotic_NN1 use_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   38 The mean daily amount of narcotic pain medication used in each group was plotted over time ( figure 2 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   38 The_AT mean_JJ daily_JJ amount_NN1 of_IO narcotic_NN1 pain_NN1 medication_NN1 used_VVN_VVD in_II each_DD1 group_NN1 was_VBDZ plotted_VVN over_II time_NNT1 (_Y figure_NN1 2_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   39 Although the bupivacaine group consumed less narcotic medication on days 3 through 6 , the trend was not statistically significant , and there was no overall difference between the 2 groups ( p = 0.37 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   39 Although_CS the_AT bupivacaine_NN1 group_NN1 consumed_VVD_VVN less_DAR narcotic_NN1 medication_NN1 on_II days_NNT2 3_MC through_II 6_MC ,_Y the_AT trend_NN1 was_VBDZ not_XX statistically_RR significant_JJ ,_Y and_CC there_EX was_VBDZ no_AT overall_JJ_NN1 difference_NN1 between_II the_AT 2_MC groups_NN2 (_Y p_ZZ1 =_FO 0.37_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   40 The trends in both groups paralleled the respective declines in pain scores .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   40 The_AT trends_NN2 in_II both_DB2 groups_NN2 paralleled_VVD_VVN the_AT respective_JJ declines_VVZ in_II pain_NN1 scores_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   41 Figure 2 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   41 Figure_NN1 2_MC ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   42 No significant difference was seen in the mean amount of narcotic analgesics used by the 2 groups ( p = 0.37 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   42 No_AT significant_JJ difference_NN1 was_VBDZ seen_VVN in_II the_AT mean_JJ amount_NN1 of_IO narcotic_NN1 analgesics_NN2 used_VVN by_II the_AT 2_MC groups_NN2 (_Y p_ZZ1 =_FO 0.37_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   43 Oral intake .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   43 Oral_JJ_NN1 intake_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   44 The mean daily total oral intake was plotted over time ( figure 3 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   44 The_AT mean_JJ daily_JJ_RR total_JJ_NN1 oral_JJ_NN1 intake_NN1 was_VBDZ plotted_VVN over_II time_NNT1 (_Y figure_NN1 3_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   45 Although there was a trend toward greater intake in the bupivacaine group , the overall difference did not reach statistical significance ( p = 0.35 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   45 Although_CS there_EX was_VBDZ a_AT1 trend_NN1 toward_II greater_JJR intake_NN1 in_II the_AT bupivacaine_NN1 group_NN1 ,_Y the_AT overall_JJ_NN1 difference_NN1 did_VDD not_XX reach_VVI statistical_JJ significance_NN1 (_Y p_ZZ1 =_FO 0.35_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   46 Figure groups in the mean amount of oral intake ( p = 0.35 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   46 Figure_NN1 groups_NN2 in_II the_AT mean_JJ amount_NN1 of_IO oral_JJ_NN1 intake_NN1 (_Y p_ZZ1 =_FO 0.35_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   47 Discussion As mentioned , several surgical and medical strategies have been undertaken in an effort to reduce post-tonsillectomy pain : Surgical technique .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   47 Discussion_NN1 As_CSA mentioned_VVN ,_Y several_DA2 surgical_JJ and_CC medical_JJ strategies_NN2 have_VH0 been_VBN undertaken_VVN in_II an_AT1 effort_NN1 to_TO reduce_VVI post-tonsillectomy_JJ_NN1 pain_NN1 :_Y Surgical_JJ technique_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   48 A series of recently published reports have suggested that surgical technique may have an impact on post-tonsillectomy pain outcomes .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   48 A_AT1_ZZ1 series_NN of_IO recently_RR published_VVN_VVD_JJ@ reports_NN2 have_VH0 suggested_VVN that_CST_DD1 surgical_JJ technique_NN1 may_VM have_VHI an_AT1 impact_NN1 on_II post-tonsillectomy_JJ_NN1 pain_NN1 outcomes_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   49 Lister et al found that pediatric patients who underwent microdebrider intracapsular tonsillotomy on one tonsil and electrocautery extracapsular tonsillectomy on the other reported significantly less pain on the microdebrider side on postoperative days 1 through 9. n4 However , Sobol et al observed no difference in postoperative pain between children who underwent microdebrider intracapsular tonsillotomy or monopolar electrocautery tonsillectomy ; also , there was no significant difference in the total number of days before patients returned to normal activity , although there was a significant difference in favor of microdebrider tonsillectomy in the return to a normal diet. n5 Polites et al found that adults who underwent Coblation-assisted tonsillectomy reported significantly less pain on postoperative days 1 and 3 than did those who underwent dissection tonsillectomy ; there was no significant difference in total lower incidence of neck pain ( and dehydration ) in children who underwent Coblation techniques as opposed to electrocautery. n7 Overall , the data seem to suggest that surgical technique may offer some benefit in the early reduction of pain following tonsillectomy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   49 Lister_NP1 et_RA21 al_RA22 found_VVD that_CST_DD1 pediatric_JJ patients_NN2 who_PNQS underwent_VVD microdebrider_NN1_VV0 intracapsular_JJ tonsillotomy_NN1 on_II one_MC1 tonsil_NN1 and_CC electrocautery_JJ extracapsular_JJ tonsillectomy_NN1 on_II the_AT other_NN1@_JJ reported_VVD_VVN significantly_RR less_DAR pain_NN1 on_II the_AT microdebrider_NN1 side_NN1 on_II postoperative_JJ days_NNT2 1_MC1 through_II 9._MC n4_FO However_RR ,_Y Sobol_NP1 et_RA21 al_RA22 observed_VVD no_AT difference_NN1 in_II postoperative_JJ pain_NN1 between_II children_NN2 who_PNQS underwent_VVD microdebrider_NN1_VV0 intracapsular_JJ tonsillotomy_NN1 or_CC monopolar_JJ electrocautery_JJ_NN1 tonsillectomy_NN1 ;_Y also_RR ,_Y there_EX was_VBDZ no_AT significant_JJ difference_NN1 in_II the_AT total_JJ_NN1 number_NN1 of_IO days_NNT2 before_II_CS patients_NN2 returned_VVN_VVD to_II normal_JJ activity_NN1 ,_Y although_CS there_EX was_VBDZ a_AT1 significant_JJ difference_NN1 in_II31 favor_II32 of_II33 microdebrider_NN1 tonsillectomy_NN1 in_II the_AT return_NN1 to_II a_AT1 normal_JJ diet._NNU n5_FO Polites_NN2 et_RA21 al_RA22 found_VVD that_CST adults_NN2 who_PNQS underwent_VVD Coblation-assisted_JJ tonsillectomy_NN1 reported_VVD_VVN significantly_RR less_DAR pain_NN1 on_II postoperative_JJ days_NNT2 1_MC1 and_CC 3_MC than_CSN did_VDD those_DD2 who_PNQS underwent_VVD dissection_NN1 tonsillectomy_NN1 ;_Y there_EX was_VBDZ no_AT significant_JJ difference_NN1 in_II total_JJ_NN1 lower_JJR incidence_NN1 of_IO neck_NN1 pain_NN1 (_Y and_CC dehydration_NN1 )_Y in_II children_NN2 who_PNQS underwent_VVD Coblation_NN1 techniques_NN2 as_II31 opposed_II32 to_II33 electrocautery._NNU n7_FO Overall_RR_NN1 ,_Y the_AT data_NN seem_VV0 to_TO suggest_VVI that_DD1_CST surgical_JJ technique_NN1 may_VM offer_VVI some_DD benefit_NN1_VV0 in_II the_AT early_JJ reduction_NN1 of_IO pain_NN1 following_VVG_II@_NN1@ tonsillectomy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   50 Steroid injections .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   50 Steroid_JJ_NN1 injections_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   51 Ohlms et al conducted a randomized , double-blind , placebo-controlled clinical trial of a single intravenous dose of dexamethasone in children and found no significant differences in postoperative pain between the treated patients and the controls. n8 Nor did they find any differences in nausea , emesis , halitosis , the need for analgesic medications , the type of diet , and activity levels .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   51 Ohlms_NP1@_NN2 et_RA21 al_RA22 conducted_VVD a_AT1 randomized_JJ@ ,_Y double-blind_JJ_NN1@ ,_Y placebo-controlled_JJ clinical_JJ trial_NN1 of_IO a_AT1 single_JJ intravenous_JJ dose_NN1 of_IO dexamethasone_NN1 in_II children_NN2 and_CC found_VVD no_AT significant_JJ differences_NN2 in_II postoperative_JJ pain_NN1 between_II the_AT treated_JJ@ patients_NN2 and_CC the_AT controls._NNU n8_FO Nor_CC did_VDD they_PPHS2 find_VVI any_DD differences_NN2 in_II nausea_NN1 ,_Y emesis_NN1 ,_Y halitosis_NN1 ,_Y the_AT need_NN1 for_IF analgesic_NN1_JJ@ medications_NN2 ,_Y the_AT type_NN1 of_IO diet_NN1 ,_Y and_CC activity_NN1 levels_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   52 Conversely , Afman et al recently reported a meta-analysis of eight randomized , controlled , double-blind studies of a single intraoperative dose of corticosteroid in children and found that there was a significant reduction in pain 2 to 7 hours postoperatively in those patients who had been administered between 0.4 and 1.0 mg/kg of dexamethasone. n9 Antibiotic injections .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   52 Conversely_RR ,_Y Afman_NP1 et_RA21 al_RA22 recently_RR reported_VVN_VVD a_AT1 meta-analysis_NN1 of_IO eight_MC randomized_VVD_JJ@ ,_Y controlled_VVD_VVN ,_Y double-blind_JJ studies_NN2 of_IO a_AT1 single_JJ intraoperative_JJ dose_NN1 of_IO corticosteroid_NN1_JJ in_II children_NN2 and_CC found_VVD_VVN that_CST there_EX was_VBDZ a_AT1 significant_JJ reduction_NN1 in_II pain_NN1 2_MC to_II 7_MC hours_NNT2 postoperatively_RR in_II those_DD2 patients_NN2 who_PNQS had_VHD been_VBN administered_VVN between_II 0.4_MC and_CC 1.0_MC mg/kg_NNU of_IO dexamethasone._NNU n9_FO Antibiotic_NN1 injections_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   53 Data from a seven-study meta-analysis conducted by Burkart and Steward demonstrated that both adult and pediatric patients who had been treated amoxicillin/clavulanate -- experienced a significantly earlier return to a normal diet and normal activity , but they found no significant difference in postoperative pain scores. n10 A similar lack of efficacy with regard to pain was found in a meta-analysis of five trials of intra- and/or postoperative antibiotics reported by Dhiwakar et al. n11 On the other hand , a single-day regimen of a topical antibiotic was shown by Mann et al to be more effective than placebo in reducing postoperative pain in adults. n12 Anesthetic injections .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   53 Data_NN from_II a_AT1 seven-study_JJ_NN1 meta-analysis_NN1 conducted_VVN by_II Burkart_NP1_NN1 and_CC Steward_NN1 demonstrated_VVD_VVN that_CST both_DB2_RR adult_NN1_JJ@ and_CC pediatric_JJ patients_NN2 who_PNQS had_VHD been_VBN treated_VVN amoxicillin/clavulanate_NN1 --_NN1 experienced_VVD_VVN a_AT1 significantly_RR earlier_JJR_RRR return_NN1_VV0 to_II a_AT1 normal_JJ diet_NN1 and_CC normal_JJ activity_NN1 ,_Y but_CCB they_PPHS2 found_VVD no_AT significant_JJ difference_NN1 in_II postoperative_JJ pain_NN1 scores._NNU n10_FO A_ZZ1 similar_JJ lack_NN1 of_IO efficacy_NN1 with_II31 regard_II32 to_II33 pain_NN1 was_VBDZ found_VVN in_II a_AT1 meta-analysis_NN1 of_IO five_MC trials_NN2 of_IO intra-_NN1_JJ and/or_CC postoperative_JJ antibiotics_NN2 reported_VVN by_II Dhiwakar_NP1 et_RA21 al._RA22 n11_FO On_II the_AT other_JJ hand_NN1 ,_Y a_AT1 single-day_JJ_NNT1 regimen_NN1 of_IO a_AT1 topical_JJ antibiotic_NN1 was_VBDZ shown_VVN by_II Mann_NP1 et_RA21 al_RA22 to_TO be_VBI more_RGR effective_JJ than_CSN placebo_NN1 in_II reducing_VVG postoperative_JJ pain_NN1 in_II adults._NNU n12_FO Anesthetic_JJ_NN1 injections_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   54 As mentioned , the influence of local anesthetic injections on reducing post-tonsillectomy pain is equivocal .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   54 As_CSA mentioned_VVN ,_Y the_AT influence_NN1 of_IO local_JJ anesthetic_JJ injections_NN2 on_II reducing_VVG post-tonsillectomy_JJ_NN1 pain_NN1 is_VBZ equivocal_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   55 The timing of injections ( i.e. , preincision or postoperative ) does not appear to have any effect on self-rated pain scores .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   55 The_AT timing_NN1 of_IO injections_NN2 (_Y i.e._REX ,_Y preincision_NN1 or_CC postoperative_JJ )_Y does_VDZ not_XX appear_VVI to_TO have_VHI any_DD effect_NN1 on_II self-rated_JJ_NN1 pain_NN1 scores_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   56 In our study , the lack of bupivacaine effect seen subjectively was confirmed by objective data -- that is , the amounts of narcotic consumption and daily oral intake .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   56 In_II our_APPGE study_NN1 ,_Y the_AT lack_NN1 of_IO bupivacaine_NN1 effect_NN1 seen_VVN subjectively_RR was_VBDZ confirmed_VVN by_II objective_JJ_NN1 data_NN --_NN1_JJ that_REX21 is_REX22 ,_Y the_AT amounts_NN2 of_IO narcotic_NN1 consumption_NN1 and_CC daily_RR_JJ oral_JJ_NN1 intake_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   57 The findings of the present study also confirm those of our earlier study. n3 However , the difficulties of assessing subjective data such as pain scores are well known , and the use of tool. n13 The half-life of bupivacaine is 2.7 hours in adults .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   57 The_AT findings_NN2 of_IO the_AT present_JJ_NN1 study_NN1 also_RR confirm_VV0 those_DD2 of_IO our_APPGE earlier_JJR study._NNU n3_FO However_RR ,_Y the_AT difficulties_NN2 of_IO assessing_VVG subjective_JJ data_NN such_II21 as_II22 pain_NN1 scores_NN2 are_VBR well_RR known_VVN ,_Y and_CC the_AT use_NN1 of_IO tool._NNU n13_FO The_AT half-life_NN1 of_IO bupivacaine_NN1 is_VBZ 2.7_MC hours_NNT2 in_II adults_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   58 Systemic absorption of bupivacaine is dependent on the total dose and concentration administered , the route of administration , vascularity at the administration site , and the use of epinephrine .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   58 Systemic_JJ absorption_NN1 of_IO bupivacaine_NN1 is_VBZ dependent_JJ on_II the_AT total_JJ_NN1 dose_NN1 and_CC concentration_NN1 administered_VVN_VVD@ ,_Y the_AT route_NN1 of_IO administration_NN1 ,_Y vascularity_NN1 at_II the_AT administration_NN1 site_NN1 ,_Y and_CC the_AT use_NN1 of_IO epinephrine_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   59 Epinephrine used at a concentration of 1:200,000 usually reduces the rate of absorption and the peak plasma concentration of bupivacaine , thus allowing for larger total doses , which may prolong its duration of action .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   59 Epinephrine_NP1@_NN1_JJ used_VVD at_II a_AT1 concentration_NN1 of_IO 1:200,000_MC usually_RR reduces_VVZ the_AT rate_NN1 of_IO absorption_NN1 and_CC the_AT peak_NN1 plasma_NN1 concentration_NN1 of_IO bupivacaine_NN1 ,_Y thus_RR allowing_VVG for_IF larger_JJR total_JJ_NN1 doses_NN2 ,_Y which_DDQ may_VM prolong_VVI its_Z' duration_NN1 of_IO action_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   60 With respect to the pharmacokinetic properties of bupivacaine , both the time it takes to achieve its maximum analgesic effect and the specific route of administration warrant further study .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   60 With_II31 respect_II32 to_II33 the_AT pharmacokinetic_JJ properties_NN2 of_IO bupivacaine_NN1 ,_Y both_DB2_RR the_AT time_NNT1 it_PPH1 takes_VVZ to_TO achieve_VVI its_Z' maximum_JJ_NN1 analgesic_NN1_JJ@ effect_NN1 and_CC the_AT specific_JJ route_NN1 of_IO administration_NN1 warrant_VV0_NN1 further_JJR@_RRR study_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   61 In the present study , we did not examine the effect of bupivacaine during the immediate postoperative period ( i.e. , within hours of administration ) , and thus we do not know if its use had an ) , significant impact on the amount of time patients spent in the recovery suite .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   61 In_II the_AT present_JJ_NN1 study_NN1 ,_Y we_PPIS2 did_VDD not_XX examine_VVI the_AT effect_NN1 of_IO bupivacaine_NN1 during_II the_AT immediate_JJ postoperative_JJ period_NN1 (_Y i.e._REX ,_Y within_II hours_NNT2 of_IO administration_NN1 )_Y ,_Y and_CC thus_RR we_PPIS2 do_VD0 not_XX know_VVI if_CSW@_CS its_Z' use_NN1 had_VHD an_AT1 )_Y ,_Y significant_JJ impact_NN1 on_II the_AT amount_NN1 of_IO time_NNT1 patients_NN2 spent_VVN_VVD in_II the_AT recovery_NN1 suite_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   62 Moreover , subcutaneous delivery of microencapsulated bupivacaine has been shown to extend its analgesic effect for as long as 96 hours without delaying its onset of action. n14 significantly reduce postoperative pain , the hypothesis that local anesthetics in general may do so should not be abandoned as newer preparations with more sustained analgesic effects become available .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   62 Moreover_RR ,_Y subcutaneous_JJ delivery_NN1 of_IO microencapsulated_JJ@ bupivacaine_NN1 has_VHZ been_VBN shown_VVN to_TO extend_VVI its_Z' analgesic_NN1_JJ@ effect_NN1 for_IF as_CS31_RG long_CS32_RR as_CS33_CSA 96_MC hours_NNT2 without_IW delaying_VVG its_Z' onset_NN1 of_IO action._NNU n14_FO significantly_RR reduce_VVI postoperative_JJ pain_NN1 ,_Y the_AT hypothesis_NN1 that_CST_DD1 local_JJ anesthetics_NN2_NN1 in_RR21 general_RR22 may_VM do_VDI so_RR should_VM not_XX be_VBI abandoned_VVN as_CSA_II@_RG@ newer_JJR preparations_NN2 with_IW more_RGR_DAR sustained_JJ analgesic_NN1_JJ@ effects_NN2 become_VV0 available_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   63 References ( n1 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   63 References_NN2 (_Y n1_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   64 ) Ginstrm R , Silvola J , Saarnivaara L. Local bupivacaine-epinephrine infiltration combined with general anesthesia for adult tonsillectomy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   64 )_Y Ginstrm_VV0 R_ZZ1 ,_Y Silvola_NP1 J_ZZ1_NP1@ ,_Y Saarnivaara_NP1 L._ZZ Local_NN1_JJ@ bupivacaine-epinephrine_NN1_JJ infiltration_NN1 combined_VVN with_IW general_JJ anesthesia_NN1 for_IF adult_NN1_JJ@ tonsillectomy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   65 Acta Otolaryngol 2005 ; 125(9):972-5. ( n2 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   65 Acta_NP1@_NN1 Otolaryngol_NP1_NN1 2005_MC ;_Y 125(9):972-5._FO (_Y n2_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   66 ) Naja MZ , El-Rajab M , Kabalan W , et al .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   66 )_Y Naja_NP1@ MZ_NP1 ,_Y El-Rajab_NP1 M_ZZ1_NN1 ,_Y Kabalan_NP1_JJ W_ZZ1_NP1@ ,_Y et_RA21 al_RA22 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   67 Pre-incisional infiltration for pediatric tonsillectomy : A randomized double-blind clinical trial .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   67 Pre-incisional_JJ infiltration_NN1 for_IF pediatric_JJ tonsillectomy_NN1 :_Y A_ZZ1_AT1@ randomized_JJ@_VVD double-blind_JJ clinical_JJ trial_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   68 Int J Pediatr Otorhinolaryngol 2005 ; 69(10):1333-41. ( n3 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   68 Int_ZZ_J J_ZZ1_NP1@ Pediatr_NP1 Otorhinolaryngol_NP1_NN1 2005_MC ;_Y 69(10):1333-41._FO (_Y n3_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   69 ) Kountakis SE .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   69 )_Y Kountakis_NP1@_NN1 SE_NP1_ND1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   70 Effectiveness of perioperative bupivacaine infiltration in tonsillectomy patients .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   70 Effectiveness_NN1 of_IO perioperative_JJ bupivacaine_NN1 infiltration_NN1 in_II tonsillectomy_NN1 patients_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   71 Am J Otolaryngol 2002 ; 23(2):76-80. ( n4 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   71 Am_VBM J_NP1@ Otolaryngol_NP1_NN1 2002_MC ;_Y 23(2):76-80._FO (_Y n4_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   72 ) Lister MT , Cunningham MJ , Benjamin B , et al .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   72 )_Y Lister_NP1 MT_NNL1 ,_Y Cunningham_NP1 MJ_NP1 ,_Y Benjamin_NP1 B_ZZ1_NP1@ ,_Y et_RA21 al_RA22 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   73 Microdebrider tonsillotomy vs. electrosurgical tonsillectomy : A randomized , double-blind , paired control study of postoperative pain .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   73 Microdebrider_VV0_NN1 tonsillotomy_NN1 vs._II electrosurgical_JJ tonsillectomy_NN1 :_Y A_ZZ1_AT1@ randomized_VVD_JJ@ ,_Y double-blind_JJ_NN1@ ,_Y paired_VVD_VVN control_NN1 study_NN1 of_IO postoperative_JJ pain_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   74 Arch Otolaryngol Head Neck Surg 2006 ; 132(6):599-604. ( n5 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   74 Arch_JJ_NN1 Otolaryngol_NN1 Head_NN1 Neck_NN1 Surg_NN1_NP1_VV0 2006_MC ;_Y 132(6):599-604._FO (_Y n5_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   75 ) Sobol SE , Wetmore RF , Marsh RR , et al .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   75 )_Y Sobol_VV0_NP1@ SE_ND1_NP1 ,_Y Wetmore_NP1 RF_NP1 ,_Y Marsh_NP1 RR_NP1 ,_Y et_RA21 al_RA22 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   76 Postoperative recovery after microdebrider intracapsular or monopolar electrocautery tonsillectomy : A prospective , randomized , single-blinded study n6 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   76 Postoperative_JJ recovery_NN1 after_II_CS microdebrider_NN1_VV0 intracapsular_JJ or_CC monopolar_JJ electrocautery_JJ_NN1 tonsillectomy_NN1 :_Y A_ZZ1_AT1@ prospective_JJ ,_Y randomized_VVD ,_Y single-blinded_JJ_NN1 study_NN1 n6_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   77 ) Polites N , Joniau S , Wabnitz D , et al .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   77 )_Y Polites_NP1@_NN2 N_ZZ1_NP1@ ,_Y Joniau_NP1 S_ZZ1_NP1@ ,_Y Wabnitz_NP1 D_ZZ1_NP1@ ,_Y et_RA21 al_RA22 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   78 Postoperative pain following coblation tonsillectomy : Randomized clinical trial .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   78 Postoperative_JJ pain_NN1 following_VVG_II@_NN1@ coblation_NN1 tonsillectomy_NN1 :_Y Randomized_JJ clinical_JJ trial_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   79 ANZ J Surg 2006 ; 76(4):226-9. ( n7 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   79 ANZ_NP1_VV0 J_NP1@_ZZ1 Surg_NP1_VV0_NN1 2006_MC ;_Y 76(4):226-9._FO (_Y n7_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   80 ) Glade RS , Pearson SE , Zalzal GH , Choi SS .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   80 )_Y Glade_VV0_NN1 RS_NN1 ,_Y Pearson_NP1 SE_NP1_ND1 ,_Y Zalzal_NP1 GH_NP1 ,_Y Choi_NP1 SS_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   81 Coblation adenotonsillectomy : An improvement over electrocautery technique ?
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   81 Coblation_NN1_NP1@ adenotonsillectomy_NN1 :_Y An_AT1 improvement_NN1 over_II electrocautery_JJ_NN1 technique_NN1 ?_Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   82 Otolaryngol Head Neck Surg 2006 ; 134(5):852-5. ( n8 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   82 Otolaryngol_VV0_NN1 Head_NN1 Neck_NN1 Surg_NN1_NP1_VV0 2006_MC ;_Y 134(5):852-5._FO (_Y n8_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   83 ) Ohlms LA , Wilder RT , Weston B. Use of intraoperative corticosteroids in pediatric tonsillectomy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   83 )_Y Ohlms_NP1@ LA_NP1 ,_Y Wilder_JJR RT_NN1 ,_Y Weston_NP1 B._NP1 Use_NN1 of_IO intraoperative_JJ corticosteroids_NN2 in_II pediatric_JJ tonsillectomy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   84 Arch Otolaryngol Head Neck Surg 1995 ; 121(7):737-42. ( n9 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   84 Arch_JJ_NN1 Otolaryngol_NN1 Head_NN1 Neck_NN1 Surg_NN1_NP1_VV0 1995_MC ;_Y 121(7):737-42._FO (_Y n9_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   85 ) Afman CE , Welge JA , Steward DL .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   85 )_Y Afman_NP1@_NN1 CE_NP1_NN1 ,_Y Welge_NP1 JA_NP1_FW ,_Y Steward_NN1_VV0@ DL_MC ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   86 Steroids for post-tonsillectomy pain reduction : Meta-analysis of randomized controlled trials .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   86 Steroids_NN2 for_IF post-tonsillectomy_JJ_NN1 pain_NN1 reduction_NN1 :_Y Meta-analysis_NN1 of_IO randomized_JJ@ controlled_JJ@ trials_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   87 Otolaryngol Head Neck Surg 2006 ; 134(2) : 181-6. ( n10 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   87 Otolaryngol_VV0_NN1 Head_NN1 Neck_NN1 Surg_NN1_NP1_VV0 2006_MC ;_Y 134(2)_FO :_Y 181-6._MCMC (_Y n10_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   88 ) Burkart CM , Steward DL .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   88 )_Y Burkart_VV0 CM_NNU ,_Y Steward_NN1_VV0@ DL_MC ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   89 Antibiotics for reduction of posttonsillectomy morbidity : A meta-analysis .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   89 Antibiotics_NN2 for_IF reduction_NN1 of_IO posttonsillectomy_NN1 morbidity_NN1 :_Y A_AT1@_ZZ1 meta-analysis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   90 Laryngoscope 2005 ; 115(6) : 997-1002. ( n11 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   90 Laryngoscope_NN1_NP1@ 2005_MC ;_Y 115(6)_FO :_Y 997-1002._MCMC (_Y n11_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   91 ) Dhiwakar M , Eng CY , Selvaraj S , McIerrow WS .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   91 )_Y Dhiwakar_VV0_NN1 M_ZZ1_NN1 ,_Y Eng_NP1 CY_NP1 ,_Y Selvaraj_NP1 S_ZZ1_NP1@ ,_Y McIerrow_NP1 WS_NP2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   92 Antibiotics to improve recovery following tonsillectomy : A systematic review .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   92 Antibiotics_NN2 to_TO improve_VVI recovery_NN1 following_VVG_II@_NN1@ tonsillectomy_NN1 :_Y A_ZZ1_AT1@ systematic_JJ review_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   93 Otolaryngol Head Neck Surg 2006 ; 134(3):357-64. ( n12 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   93 Otolaryngol_VV0_NN1 Head_NN1 Neck_NN1 Surg_NN1_NP1_VV0 2006_MC ;_Y 134(3):357-64._FO (_Y n12_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   94 ) Mann EA of topical antibiotic therapy on recovery after tonsillectomy in adults .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   94 )_Y Mann_NP1 EA_NP1 of_IO topical_JJ antibiotic_NN1 therapy_NN1 on_II recovery_NN1 after_II_CS tonsillectomy_NN1 in_II adults_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   95 Otolaryngol Head Neck Surg 1999 ; 121(3):277-82. ( n13 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   95 Otolaryngol_VV0_NN1 Head_NN1 Neck_NN1 Surg_NN1_NP1_VV0 1999_MC ;_Y 121(3):277-82._FO (_Y n13_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   96 ) Collins SL , Moore RA , McQuay HJ .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   96 )_Y Collins_NP1 SL_NP1 ,_Y Moore_NP1 RA_NNA ,_Y McQuay_NP1 HJ_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   97 The visual analogue pain intensity scale : What is moderate pain in millimetres ?
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   97 The_AT visual_JJ analogue_JJ_NN1 pain_NN1 intensity_NN1 scale_NN1 :_Y What_DDQ is_VBZ moderate_JJ pain_NN1 in_II millimetres_NNU2 ?_Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   98 Pain 1997 ; 72(1-2):95-7. ( n14 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   98 Pain_NN1 1997_MC ;_Y 72(1-2):95-7._FO (_Y n14_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0   99 ) Kopacz DJ , Bernards CM , Allen HW , et al .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0   99 )_Y Kopacz_VV0_NN1 DJ_NN1 ,_Y Bernards_NP2 CM_NNU ,_Y Allen_NP1 HW_NP1 ,_Y et_RA21 al_RA22 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0  100 A model to evaluate the pharmacokinetic and pharmacodynamic variables of extended-release products using in vivo tissue microdialysis in humans : Bupivacaine-loaded microcapsules .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0  100 A_AT1 model_NN1 to_TO evaluate_VVI the_AT pharmacokinetic_JJ_NN1@ and_CC pharmacodynamic_JJ variables_NN2 of_IO extended-release_JJ_NN1 products_NN2 using_VVG in_JJ21 vivo_JJ22 tissue_NN1 microdialysis_NN1 in_II humans_NN2 :_Y Bupivacaine-loaded_JJ_NN1 microcapsules_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0  101 Anesth Analg 2003 ; 97(1):124-31 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0  101 Anesth_NP1@_NN1 Analg_NP1_NN1 2003_MC ;_Y 97(1):124-31_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0  102 By Tammara L. Watts , MD , PhD and Stilianos E. Kountakis , MD , PhD From the Department of Otolaryngology-Head and Neck Surgery , Medical College of Georgia , Augusta .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0  102 By_II Tammara_NP1 L._ZZ Watts_NP1 ,_Y MD_NNA ,_Y PhD_NN1 and_CC Stilianos_NP1 E._NP1 Kountakis_NP1 ,_Y MD_NNA ,_Y PhD_NN1 From_II the_AT Department_NN1 of_IO Otolaryngology-Head_NN1 and_CC Neck_NN1_VV0@ Surgery_NN1 ,_Y Medical_JJ College_NN1 of_IO Georgia_NP1 ,_Y Augusta_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0  103 Corresponding author : Stilianos E. Kountakis , MD , Department of Otolaryngology-Head and Neck Surgery , Medical College of Georgia , 1120 15th St. , Augusta , GA 30912 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0  103 Corresponding_JJ_VVG author_NN1 :_Y Stilianos_NP1 E._NP1 Kountakis_NP1 ,_Y MD_NNA ,_Y Department_NN1 of_IO Otolaryngology-Head_NN1 and_CC Neck_NN1_VV0@ Surgery_NN1 ,_Y Medical_JJ College_NN1 of_IO Georgia_NP1 ,_Y 1120_MC 15th_MD St._NP1 ,_NP1 Augusta_NP1 ,_Y GA_NP1 30912_MC ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  A    0  104 E-mail : skountakis@mcg.edu
SENTPOS COCA_acad_wlp_2009_10_FILE##4080434 COCA  B    0  104 E-mail_NN1_VV0@ :_Y skountakis@mcg.edu_FO
